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The receptor activator of nuclear factor-kappa B ligand (RANKL) mediates osteoclast
differentiation and functions by inducing Ca2+ oscillations, activating mitogen-activated
protein kinases (MAPKs), and activating nuclear factor of activated T-cells type c1
(NFATc1) via the RANK and tumor necrosis factor (TNF) receptor-associated factor
6 (TRAF6) interaction. Reactive oxygen species (ROS) also plays an important role
during osteoclastogenesis and Sestrin2, an antioxidant, maintains cellular homeostasis
upon stress injury via regulation of ROS, autophagy, and inflammation. However,
the role of Sestrin2 in osteoclastogenesis remains unknown. In this study, we
investigated the role of Sestrin2 in the RANKL-RANK-TRAF6 signaling pathway during
osteoclast differentiation. Deletion of Sestrin2 (Sesn2) increased bone mass and
reduced the number of multinucleated osteoclasts on bone surfaces. RANKL-induced
osteoclast differentiation and function decreased in Sesn2 knockout (KO) bone marrow-
derived monocytes/macrophages (BMMs) due to inhibition of NFATc1 expression, but
osteoblastogenesis was not affected. mRNA expression of RANKL-induced specific
osteoclastogenic genes and MAPK protein expression were lower in Sesn2 KO BMMs
than wild-type (WT) BMMs after RANKL treatment. However, the Sesn2 deletion did
not affect ROS generation or intracellular Ca2+ oscillations during osteoclastogenesis.
In contrast, the interaction between TRAF6 and p62 was reduced during osteoclasts
differentiation in Sesn2 KO BMMs. The reduction in the TRAF6/p62 interaction and
TRAP activity in osteoclastogenesis in Sesn2 KO BMMs was recovered to the WT level
upon expression of Flag-Sesn2 in Sesn2 KO BMMs. These results suggest that Sestrin2
has a novel role in bone homeostasis and osteoclasts differentiation through regulation
of NFATc1 and the TRAF6/p62 interaction.
Keywords: reactive oxygen species, autophagy inducer, osteoclast differentiation, antioxidant proteins, bone
homeostasis
INTRODUCTION
Bone is a living organ that renews throughout life via bone remodeling. Bone remodeling results
from a balanced collaboration between bone formation by osteoblasts and bone resorption by
osteoclasts. When the homeostatic equilibrium of this process is broken, bone diseases, such
as periodontitis, osteoporosis, osteopetrosis, autoimmune arthritis, and bone tumors, develop
Frontiers in Cell and Developmental Biology | www.frontiersin.org 1 March 2021 | Volume 9 | Article 646803
fcell-09-646803 March 22, 2021 Time: 13:41 # 2
Oh et al. Role of Sestrin2 in Osteoclastogenesis
(Takayanagi, 2007; Crockett et al., 2011; Okamoto et al.,
2017; Tsukasaki and Takayanagi, 2019). Mature osteoclasts
are differentiated multinucleated cells (MNCs) derived from
hematopoietic cells of the mononuclear lineage; the two essential
factors required for osteoclast formation are macrophage colony-
stimulating factor (M-CSF) and receptor activator of nuclear
factor-κB ligand (RANKL), which is secreted by osteoblasts
(Boyle et al., 2003; Takayanagi, 2007). The interaction between
RANKL and RANK receptor activates tumor necrosis factor
(TNF) receptor-associated factor 6 (TRAF6). TRAF6 activates
downstream signals, including nuclear factor-κB (NF-κB), and
mitogen-activated protein kinases (MAPKs), such as extracellular
regulated kinase (ERK), c-jun N-terminal kinase (JNK), and
p38 (Takayanagi et al., 2002b). In addition, the RANKL-
RANK interaction leads to an increase in the intracellular
reactive oxygen species (ROS) level and to oscillations in the
intracellular Ca2+ concentration ([Ca2+]i). Ultimately, RANKL-
mediated ROS generation and [Ca2+]i oscillations induce nuclear
translocation of nuclear factor of activated T-cells cytoplasmic 1
(NFATc1), formation of MNCs, and bone resorption (Takayanagi
et al., 2002a; Lee et al., 2005; Kim et al., 2010).
Ca2+ is an essential second messenger in universal signaling
cascade and plays a critical role in cellular life and death decisions,
such as cell proliferation, gene expression, contraction, secretion,
metabolism, cell survival, and apoptosis (Hempel and Trebak,
2017). The Ca2+ signaling pathways associate with other cellular
signaling systems, including the ROS pathway. Although ROS
can damage cellular components, including protein, lipids, and
DNA, at moderate levels, ROS function as crucial signaling
molecules in some physiological processes via their oxidizing
activity (Gorlach et al., 2015; Hempel and Trebak, 2017). ROS and
Ca2+ signaling can be regarded as bidirectional actions because
ROS can regulate cellular Ca2+ signaling and Ca2+ signaling is
key for ROS production during bone remodeling (Agidigbi and
Kim, 2019). Thus, dysfunction in one of these systems might
affect the other system leading to harmful effects and various
disorders (Lee et al., 2005; Kim et al., 2010, 2012, 2013; Srinivasan
et al., 2010; Domazetovic et al., 2017).
Sestrins, a highly conserved protein family, are induced
by various environmental stresses, including DNA damage,
oxidative stress, and nutritional stress. Sestrins protect and
maintain cell and tissues homeostasis upon stress injury by
negatively regulating ROS accumulation and the mammalian
target of rapamycin (mTOR) protein kinase signaling. There are
three Sestrin isoforms in vertebrates: Sestrin1 (Sesn1, PA26),
Sestrin2 (Sesn2, Hi95), and Sestrin3 (Sesn3). Sesn1 associates
with autophagy-related genes and negatively regulates the
mTOR complex 1 (mTORC1) and ROS production in immune
cells. Sesn2, an antioxidant, activates AMP-activated protein
kinase (AMPK) and inhibits mTORC1 signaling. Sesn3 also
suppresses mTORC1 activity and maintains Akt activity by
activating the AMPK-TSC1/2 signaling axis (Wang et al., 2019;
Kim et al., 2020).
Human Sestrin2 (hSestrin2) consists of three subdomains:
Sesn-A, Sesn-B, and Sesn-C. Sesn-A functions as an active alkyl
hydroperoxide reductase and is essential for the antioxidant
effect. Sesn-B contains a leucine-binding site and interacts
with leucine. Sesn-C interacts with the Rag GTPase-activating
protein complex to regulate AMPK and mTORC1 signaling
(Kim H. et al., 2015; Saxton et al., 2016). Sesn2 also protects
cells from oxidative stresses by activating autophagic regulators
through the kelch-like ECH-associated protein 1 (Keap1)-nuclear
factor erythroid-2-related factor 2 (Nrf2) pathway and through
interaction with p62, an adaptor protein for autophagy (Bae et al.,
2013; Rhee and Bae, 2015). p62 activates mTORC1-dependent
nutrient sensing, NF-κB-mediated inflammatory responses, and
the Nrf2-activated antioxidant defense in hepatocarcinoma cells
(Taniguchi et al., 2016). Interestingly, several studies have shown
that p62 is an atypical protein kinase C (aPKC) interacting
protein that mediates the TRAF6-p62-aPKC signaling axis
in RANKL-induced osteoclastogenesis (Duran et al., 2004;
McManus and Roux, 2012; Li et al., 2014). Expression of NF-
κB and MAPKs associate with activation of RANKL-RANK-
TRAF6 downstream signaling, which regulates expression of
NFATc1 and the functions of MNCs during osteoclastogenesis
(Takayanagi et al., 2000; Boyle et al., 2003). Although it has
been shown that Sesn2 protects cells from harmful stresses
by inhibiting mTORC1 and ROS and by regulating autophagy
via the Sesn2 and Keap1-p62 interaction, the regulatory
role of Sesn2 during the maintenance of bone homeostasis
remains unknown.
In this study, we used Sesn2 knockout (KO) mice to investigate
the role of Sesn2 in the RANK-TRAF6 downstream signaling




Sesn2 plasmid (pcDNA3.1 Flag-Sesn2; plasmid #61868) was
obtained from Addgene (Cambridge, MA, United States).
Lentiviral pLVX-EF1α-IRES-Puro (EIP) vector (#631988) was
obtained from Takara Bio United States, Inc. (Mountain View,
CA, United States). Anti- Sesn2 antibodies were obtained
from ProteinTech (Rosemont, IL, United States). Anti-NFATc1
and anti-TRAF6 antibodies were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA, United States). Anti-phosphor
(p)-p38, anti-p-ERK, anti-p-JNK, and anti-IκBα antibodies were
obtained from Cell Signaling (Beverly, MA, United States). Anti-
p62 antibodies were obtained from Abnova (Taipei City, Taiwan).
Anti-tubulin antibodies were obtained from Developmental
Studies Hybridoma Bank (Iowa city, IA, United States).
Fura-2/AM was purchased from Invitrogen (Carlsbad, CA,
United States). Pluronic F-127 was obtained from Molecular
Probes (Eugene, OR, United States). RANKL was purchased
from R&D Systems (Minneapolis, MN, United States). All
other chemicals were purchased from Sigma-Aldrich (St. Louis,
MO, United States).
Animals and Cell Culture
Sesn2 KO mice in the C57BL/6 background were generated
as described (Woo et al., 2009) and all animal care and
experimental procedures complied with institutional guidelines
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and were approved by the Institutional Animal Care and Use
Committee (IACUC) in Yonsei University (IACUC approval
no. 2020-0031). The femur and tibia were isolated from 4
to 6-week-old male mice as described previously (Son et al.,
2019). All cells derived from bone marrow of femur and
tibia were collected and cultured in α-minimum essential
medium (α-MEM) (Gibco, Grand Island, NY, United States)
medium containing 10% fetal bovine serum (FBS) (Gibco)
and 30 ng/mL M-CSF. The following day, non-adherent
cells in media were collected and seeded on adequate plates
containing 30 ng/mL M-CSF (PeproTech, Rocky Hill, NJ,
United States). After 3 days, non-adherent cells were washed out
with fresh media, and adherent cells were used as bone marrow-
derived monocytes/macrophages (BMMs). Primary osteoblast
cell cultures were prepared as described previously (Son et al.,
2018). In brief, the calvariae of 1∼3-day-old mice were digested
with an enzyme solution containing 0.1% collagenase and 0.1%
dispase. The isolated osteoblastic cells were cultured for 4 days
in α-MEM supplemented with 10% FBS and 1% antibiotic-
antimycotic solution in a humidified incubator containing 5%
CO2. Cells were plated at a density of 3 × 104 cells/well in 24-
well plates. Osteoblastic differentiation of cells was induced by
50 µg/ml ascorbic acid and 10 mM β-glycerophosphate when
cells reached confluence.
Micro-CT Scanning and Bone
Histomorphometry
The distal femoral bone structure was analyzed by Advanced
Institutes of Convergence Technology (Genoss Co., Ltd., Suwon,
South Korea) after removing soft tissues. Two-dimensional
images were analyzed using CTAn software (v.1.16, Bruker,
Billerica, MA, United States). The dissected femurs of 13∼15-
week-old male mice were fixed in 4% paraformaldehyde
overnight at 4◦C, decalcified in 15% ethylenediaminetetraacetic
acid and embedded in paraffin. Paraffin-embedded sections
were cut and stained with tartrate-resistant acid phosphatase
(TRAP)/alkaline phosphatase (ALP) stain kit (Wako, Osaka,
Japan) according to the manufacturer’s protocols. Staining
was visualized with an Olympus IX71/F22PH microscope
(Tokyo, Japan) and measurements performed with Bio-
Quant software (Bioquant Image Analysis Co., Nashville,
TN, United States).
Alkaline Phosphatase (ALP) Activity
Assay and Alizarin Red S (ARS) Staining
After osteogenic induction, cells were rinsed two times with
phosphate buffered saline, fixed in 4% paraformaldehyde for
10 min, and then rinsed with deionized water three times.
ALP and alizarin red S (ARS) were added into cells for the
staining during 30 min. Images of each sample were acquired
using a CCD camera. To quantify matrix mineralization, cells
were washed once with PBS solution and incubated in 100 mM
cetylpyridinium chloride for ARS and alkaline phosphatase
yellow for ALP. The concentration of ARS was measured using a
microplate spectrophotometer at a 562 nm wavelength and ALP
activity was measured at the wavelength of 405 nm.
Tartrate-Resistant Acid Phosphatase
(TRAP) Stain Assay
Bone marrow-derived monocytes/macrophages of WT and Sesn2
KO mice were seeded in 48-well plates at a concentration of
3 × 104 cells/well and cultured in α-MEM containing 10%
FBS with 30 ng/ml M-CSF and 60 ng/ml RANKL. The culture
medium was replaced every 2 days. After 6 days, a TRAP stain
assay was performed to confirm the cell differentiation rate.
TRAP+ cells were stained using a Leukocyte Acid Phosphate
Assay Kit (Sigma-Aldrich) by following the manufacturer’s
procedure and number of TRAP+ cells (containing ≥3 nuclei)
were counted.
Resorption Assay
Bone marrow-derived monocytes/macrophages were seeded on
Osteo Assay surface (Corning, Corning, NY, United States) and
differentiated into osteoclasts. After 6 days, cells were washed
with sodium hypochlorite solution for 1 h at room temperature.
Bone slices were imaged, and resorption pits were photographed
and analyzed by using Bio-Quant software.
Real-Time RT-PCR Analysis
Total RNA was isolated by using Trizol reagent (Thermo
Fisher Scientific, Waltham, MA, United States) according to the
manufacturer’s instruction. Total RNA was reverse transcribed to
cDNA with the use of MultiScribeTM Reverse Transcriptase
(Applied Biosystems, Foster City, CA, United States).
Quantitative PCR was performed to measure the relative mRNA
levels using the StepOnePlus Real-Time PCR System (Applied
Biosystems) with a 20 µl reaction mix containing cDNA,
0.2 µM primers, and 10 µl of SensiFASTTM SYBR R© Hi-ROX Kit
(BIOLINE, London, United Kingdom). The relative amount of
mRNA normalized to 18S was calculated using the delta-delta
method. The following primers were used: cathepsin K (CTSK)
forward: 5′-GAAGAAGACTCACCAGAAG CAG-3′, reverse:
5′-YCCAGGTTATGGGCAGAGATT-3′; tartrate-resistant acid
phosphatase 5 (ACP5, TRAP) forward: 5′-GCAACATCCCCT
GGTATGTG-3′, reverse: 5′-GCAAACGGTAGTAAGGGCTG-
3′; dendrocyte expressed seven transmembrane protein
(DC-STAMP) forward: 5′-GGGGACTTATGTGTTTCCACG-
3′, reverse: 5′-ACAAAGCAACAGACTCCCAAAT-3′; d2
isoform of the vacuolar ATPase v0 domain (Atp6v0d2)
forward: 5′-CTGGTTCGAGGATGCAAAGC-3′, reverse: 5′-
GTTGCCATA GTCCGTGGTCTG-3′; osteoclast-associated
receptor (OSCAR) forward: 5′-CCTAGCCTCATACCCCCAG-
3′, reverse: 5′-CGTTGATCCCAGGAGTCACAA-3′; αv integrin
forward: 5′-CCGTGGACTTCTTCGAGCC-3′, reverse: 5′-CT
GTTGAATCAAACTCAATGGGC-3′; β3 integrin forward:
5′-CCACACGAGGCGTGAACTC-3′, reverse: 5′-CTTCAGGTT
ACATCGGGGTGA-3′; macrophage colony-stimulating factor
1 receptor (mCsf1r, M-CSFR) forward: 5′-GGACCTACC
GTTGTACCGAG-3′, reverse: 5′-CAAGAGTGGGCCGGATC
TTT-3′; Sestrin2 (Sesn2) forward: 5′-GCAGATCTATGATCG
TAGCGGA-3′, reverse: 5′-GCTCTAGATCAGGTCATGTAGC-
3′; NFATc1 forward: 5′-CAAGTCTCACCACAGGGCTCAC
TA-3′, reverse: 5′-GCGTGAGAGGTTCATTCTCCAAGT-3′;
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18S forward: 5′-ACCGCAGCTAGGAATGGA-3′, reverse:
5′-GCCTCAGTTCCGAAAACCA-3′.
Measurement of [Ca2+]i
The cells were seeded on cover glass in a 35-mm dishes
(5 × 104 cells/coverslip) and stimulated with RANKL for the
indicated times. The cells were loaded with 5 µM Fura-2/AM
and 0.05% Pluronic F-127 for 30 min in physiological salt
solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM
CaCl2, 10 mM HEPES, 10 mM glucose, 310 mOsm, pH 7.4)
at room temperature. Fura-2/AM fluorescence was measured
using excitation wavelengths of 340 and 380 nm, and emitted
fluorescence 510 nm (Ratio = F340/F380) was collected and
monitored at 2 s intervals using a CCD camera (Universal
Imaging Co., Downingtown, PA, United States). All data were
analyzed using MetaFluor software (Molecular Devices, San Jose,
CA, United States).
Measurement of Intracellular ROS
The cells were seeded in 12-well plate with cover glass at a
density of 1.5 × 105 cells/well. ROS was detected using the
fluorescent probe 5-(and-6)-carboxy-2′,7′ dichlorofluorescein
diacetate (DCFDA). The cells were exposed to 60 ng/ml
RANKL and 10 µM DCFDA for 30 min and examined with
a laser-scanning confocal microscope (model LSM 510; Carl
Zeiss) with a GFP filter set. The mean relative fluorescence
intensity for each field was measured with a Zeiss vision
system and averaged.
Western Blot and Immunoprecipitation
Whole cell lysates were extracted in RIPA buffer (Tech &
Innovation, Seoul, South Korea), and centrifuged at 12,000 × g
for 10 min at 4◦C. Supernatant was collected, and protein
was measured using Pierce BCA Protein Assay Kit (Thermo
Fisher Scientific, Waltham, MA, United States). Extracts were
subjected to 8–10% SDS-PAGE and transferred to polyvinylidene
difluoride membranes (Immobilon-P, Millipore Corp., Bedford,
MA, United States). The membranes were blocked with 5%
skimmed milk and probed with primary antibodies in 5%
BSA in TBS-T overnight at 4◦C. The primary antibodies
were used as follows: NFATc1 (1:750), Sesn2 (1:1000), p-JNK
(1:1000), p-ERK (1:1000), p-p38 (1:1000), IκBα (1:1000), TRAF6
(1:1000), p62 (1:4000), actin (1:1000), and tubulin (1:5000).
Membranes were washed and exposed to horseradish peroxidase-
conjugated secondary antibodies for 1 h. The antigen-antibody
complexes were detected with an ECLTM Prime Western Blotting
Detection Reagent (Amersham Biosciences, Piscataway, NJ,
United States). Quantification was performed by densitometry
using ImageJ. For immunoprecipitation, 700–1000 µg of protein
was incubated with 1 µg anti–rabbit TRAF6 antibody at
4◦C overnight with rotation. Protein G-Sepharose was added
and incubated with rotation for 2 h at 4◦C. Beads were
collected by centrifugation at 5000 rpm for 30 s, boiled in
2× SDS sample buffer at 95–100 centigrade for 10 min,
loaded on an SDS-PAGE, and analyzed by immunoblotting
for TRAF6 and p62.
DNA Transfection
Approximately 1∼5 × 105 BMMs were seeded on a 35-mm dish
and incubated in antibiotic-free medium. After 24 h, DNA was
mixed with 250 µl of Lipofectamine 2000 (Invitrogen) and 250 µl
of Opti-MEM, incubated for 20 min at room temperature before
adding the cell. The transfected cells were assayed at 24 h after
post-transfection.
Vector Construction and Transfection
Using Lentiviral System
A 1.4 kb full-length human Flag-Sesn2 cDNA was subcloned into
the pLVX-EIP vector (Takara) according to the manufacturer’s
instructions. The recombinant reaction was generated pLVX-
EIP-Flag-Sesn2, which is engineered to express Flag-Sesn2, and
pLVX-EIP was a control. Lentivirus packaging was performed
according to the manufacturer’s instruction by co-transfection
of these vectors and packaging mixtures (Addgene) into 293T
cells using Lipofectamine 2000 and incubated for 24 h. The
viral supernatant was harvested after 48–72 h, and titers were
determined. Cultured BMMs were infected with the pLVX-EIP-
Flag-Sesn2 or control virus pLVX-EIP and incubated for 24 h
before treatment with 50 ng/ml RANKL for the indicated times
to induce osteoclastogenesis.
Statistical Analysis
Data were presented as mean ± standard error of the
mean (S.E.M.) from at least 3 independent experiments.
Statistical significance was determined by using a Student’s
t-test or ANOVA test. Statistical significance was set at
p < 0.05 level.
RESULTS
Deficiency of Sesn2 Increases Bone
Mass
Intracellular ROS levels directly affected RANKL-induced
osteoclast differentiation and bone density, and Sens2 functions
as an antioxidant that suppresses ROS by activating AMPK
and inhibiting mTORC1. Therefore, we examined whether the
deletion of Sesn2 alters bone phenotypes in vivo by dissecting the
femurs from wild-type (WT) and Sesn2 KO male mice, measuring
bone mass by micro-radiographical analysis, and measuring
osteoclastogenesis by histomorphological analysis using TRAP
staining. The bone mass [bone volume/total volume (BV/TV)]
and trabecular number (Tb.N) of Sesn2 KO femurs were higher
than WT femurs (∼35.6 and ∼31.8%, respectively), whereas
trabecular separation (Tb.Sp) was ∼21.9% lower in femurs of
Sesn2 KO mice than WT femurs (Figure 1A). TRAP-stained
bone sections were used to identify osteoclasts within femoral
metaphysis and to quantify surface measurements. Osteoclast
surface as a percentage of total bone surface (Oc.S/BS) and
the number of osteoclasts over total bone surface (N.Oc/BS) in
Sesn2 KO sections were lower than WT sections (∼30.2 and
∼33.5%, respectively; Figure 1B). These results indicated that
the increase in bone density in Sens2 KO mice may result from
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FIGURE 1 | The skeletal phenotype is altered in Sesn2 KO mice. For the in vivo experiments, distal femoral bones were isolated from WT and Sesn2 KO male mice
and analyzed histologically and by micro-computed tomography (µCT). (A) Micro-radiographic analyses of femur obtained from 13 to 15-week old WT (n = 6) and
Sesn2 KO mice (n = 9). The bone mass increased in Sesn2 KO mice. Bone volume over total volume (BV/TV), trabecular thickness (Tb.Th), trabecular number
(Tb.N), and trabecular separation (Tb.Sp) were expressed as mean ± S.E.M. *p < 0.05 and **p < 0.01 compared with WT mice. N.S. = not significant (Scale
bar = 500 µm). (B) Trabecular surfaces of sectioned femurs from WT (n = 5) and Sesn2 KO mice (n = 7) were TRAP-stained. TRAP+ osteoclasts along the
trabecular surfaces on bone sections are indicated by arrows. There were fewer osteoclasts on the bone surface of Sesn2 KO mice than WT mice. The percentages
of TRAP-labeled osteoclast surface over bone surface (Oc.S/BS) were calculated, and the results are presented as fold-change relative to WT mice (Scale
bar = 100 µm). Oc.S/BS and number of osteoclast over bone surface (N.Oc/BS) were measured using Bio-Quant software and expressed as mean ± S.E.M.
*p < 0.05 compared with WT.
decreases in the ratio and number for TRAP+ osteoclasts on
the bone surface.
Sens2 Modulates Osteoclast
Differentiation and Function in vitro
We examined the effects of Sens2 on osteoblast differentiation
in calvarial cells after treatments of ascorbic acid and
β-glycerophosphate and on osteoclast differentiation of
BMMs after RANKL treatment. ARS and ALP activity data
showed that Sesn2 expression did not affect osteoblastogenesis
(Figure 2A). We then investigated the roles of Sens2 on
osteoclastogenesis in M-SCF-treated and RANKL-treated WT
and Sesn2 KO BMMs. The number of TRAP+ osteoclasts,
especially TRAP+ MNCs with more than 10 nuclei, was ∼46.3%
lower in Sesn2 KO BMMs than in WT BMMs (Figure 2B).
To evaluate whether defects in osteoclastogenesis result in
osteoclasts with impaired function in Sesn2 KO mice, we
performed a pit formation assay in WT and Sesn2 KO BMMs.
The formation of pits and resorbed areas were ∼51.5% lower in
Sesn2 KO BMMs than in WT BMMs (Figure 2C). To confirm
the inhibitory effect of the Sesn2 KO on osteoclastogenesis,
we examined NFATc1 expression. Upon RANKL treatment,
NFATc1 protein expression was induced and sustained in WT
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FIGURE 2 | Deletion of Sesn2 inhibits osteoclast differentiation. (A) Primary calvarial osteoblasts derived from WT and Sesn2 KO mice were stained for ALP and
ARS after 14 day of cell culture (n = 4). The Sesn2 deletion had no effects on osteoblast differentiation in Sesn2 KO mice. N.S. = not significant. (B) Primary BMMs
derived from WT and Sesn2 KO mice were TRAP-stained after 6 days of cell culture (n = 4). After staining, TRAP+ MNCs with more than three nuclei were scored as
osteoclasts. Osteoclast differentiation was reduced in Sesn2 KO mice (Scale bar = 50 µm). Data were expressed as mean ± S.E.M. *p < 0.05, **p < 0.01, and
***p < 0.001 compared with RANKL-treated WT mice. (C) BMMs were plated on a pit assay plate and cultured for 6 days (n = 4). The attached cells were removed
and photographed under a light microscope. Pit areas were quantified using Bio-Quant software (Scale bar = 50 µm). RANKL-induced bone resorption was
inhibited in Sesn2 KO BMMs. The data were normalized to the resorptive area in RANKL-treated BMMs from WT mice. Results were expressed as mean ± S.E.M.
*p < 0.05 compared with RANKL-treated WT mice. (D) Expression of NFATc1 (90∼110 kDa), Sestrin2 (54 kDa), and tubulin (50 kDa) in WT and Sesn2 KO BMMs
after RANKL stimulation were quantified by immunoblotting and ImageJ analysis (n = 6). Expression of NFATc1 was lower in Sesn2 KO BMM cells than in WT BMM
cells. Data were normalized to the expression in cells from WT mice and expressed as mean ± S.E.M. *p < 0.05, **p < 0.01, and ***p < 0.001 compared with WT.
BMMs, whereas NFATc1 protein expression was reduced in
Sesn2 KO BMMs (∼88.0% in day 1 of RANKL treatments).
The Sens2 protein level increased in WT BMMs on day 1 after
RANKL treatment, but reduced thereafter (Figure 2D). These
results demonstrated that Sens2 regulates osteoclasts, but not
osteoblasts, differentiation and function.
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Deletion of Sesn2 Correlates Negatively
With Genes That Regulate Osteoclast
Differentiation
Osteoclast differentiation, maturation, and function are regulated
by specific osteoclastogenic genes, including NFATc1, CTSK,
TRAP, DC-STAMP, Atp6v0d2, OSCAR, αvβ3 integrin, and
mCsf1r (Boyle et al., 2003; Asagiri and Takayanagi, 2007;
Okamoto et al., 2017; Tsukasaki and Takayanagi, 2019). We used
real-time PCR to investigate the effects of Sesn2 on expression of
these genes during osteoclast differentiation of BMMs after 2 days
of RANKL treatments. Except for mCsf1r, mRNA expression
of most of the genes was lower in Sesn2 KO BMMs indicating
that Sens2 regulates maturation and function during osteoclast
differentiation (Figure 3A). Expressions of NF-κB and MAPKs
including ERK, JNK, and p38, correlate closely with activation
of RANKL-TRAF6 downstream signals during osteoclastogenesis
(Boyle et al., 2003). To confirm the effect of Sesn2 on expressions
of MAPKs, we examined protein expression of MAPKs and
IκBα upon RANKL stimulation in WT and Sesn2 KO BMMs.
Activations of NF-κB by reduced degradation of IκBα proteins
and MAPKs after RANKL treatment was lower in Sesn2 KO
BMMs than in WT BMMs. p-ERK expression increased in
WT BMMs during the first 10 min of RANKL treatment,
but expression diminished thereafter (Figure 3B). These results
suggested that Sens2 acts on osteoclast differentiation and
function by regulating osteoclastogenic genes in RANKL-TRAF6
downstream pathway.
Sens2 Regulates Osteoclastogenesis
Through Interaction Between TRAF6
and p62
Sens2 suppresses the generation and action of ROS, thus
we examined the effects of Sens2 on ROS generation and
induction of [Ca2+]i oscillations upon RANKL stimulations
in WT and Sesn2 KO BMMs. We observed that the lack of
Sesn2 did not affect the amount of ROS produced and the
number of [Ca2+]i oscillation spikes upon RANKL treatment
(Figures 4A,B). Because Sesn2 activates autophagic degradation
and interaction with p62 (Bae et al., 2013), we examined
the interaction of TRAF6 with p62 in WT and Sesn2 KO
BMMs to determine if Sesn2 affects the TRAF6-p62 interaction
and induction of osteoclastogenesis. Co-immunoprecipitation
of p62 and TRAF6 upon RANKL stimulation showed that
fewer TRAF6-p62 complexes were present in Sesn2 KO
BMMs than in WT BMMs, thus dissociation of TRAF6-p62
complexes were facilitated in Sesn2 KO BMMs (Figure 4C).
We also performed co-immunoprecipitation and TRAP assays
after transient expression of Sesn2 in WT and Sesn2 KO
BMM to determine whether TRAF6-p62 interactions increase
upon recovery of Sesn2 expression and whether abnormal
osteoclastogenesis is rescued by overexpression of Sesn2. Upon
Sesn2 expression and RANKL stimulation, binding of TRAF6
to p62 in Sesn2 KO BMMs increased to levels observed in WT
BMMs (Figure 4D). In addition, upon Sens2 overexpression,
the abnormal osteoclast differentiation observed in Sesn2 KO
BMMs was returned to normal and levels of TRAP+ MNCs
increased to levels found in WT BMMs (Figure 4E). These
results indicated that Sesn2 regulates RANKL-induced osteoclast
differentiation and function by mediating the interaction
between TRAF6 and p62.
DISCUSSION
In this study, we demonstrated a novel role of Sesn2 to regulate
interactions between TRAF6 and p62 during osteoclastogenesis.
We also provided evidence that Sesn2 modulates the activities of
NF-κB, MAPKs, as well as NFATc1 downstream signaling during
osteoclasts differentiation. Sesn2 KO mice had an high bone mass
phenotype caused by a reduction in osteoclast differentiation
through inhibition of expression of the osteoclastogenic genes
NF-κB, MAPKs, and NFATc1, but not dependent on the rate
of osteoblast differentiation or changes in intracellular ROS
and Ca2+ levels (Figure 5). These findings suggest that Sesn2
regulates RANKL-induced NFATc1 activation during late stage
osteoclast differentiation through the TRAF6/p62 interaction-
mediated NF-κB and MAPKs pathways.
It has been shown that increases in [Ca2+]i and induction
of Ca2+ oscillations play important roles in RANKL-induced
osteoclastogenesis (Takayanagi et al., 2002a). Increases in ROS
through the RANKL-RANK-TRAF6 signaling axis activate
MAPKs and differentiation to multinucleated osteoclasts, and
these ROS-induced effects are inhibit by antioxidants, such
as nicotinamide adenine dinucleotide phosphate (NADPH)
oxidases 1 (NOX1) and Rac1, an activator of the various
NOX family members (Lee et al., 2005). We demonstrated
previously that Rac1-mediated ROS levels increased in a
deletion mutant of peroxiredoxin II, a thiol-based peroxide
reductase, and induced Ca2+ oscillations, as well as osteoclast
differentiation and function during osteoclastogenesis (Kim
et al., 2010). Previous reports on ROS production and
RANKL-induced osteoclastogenesis have shown that ROS levels
regulate expression and activity of differentiation factors during
osteoclastogenesis, thereby determining the number of mature
osteoclasts and bone density, but that ROS levels do not affect
osteoblastogenesis (Kim et al., 2010, Kim J.H. et al., 2015;
Goettsch et al., 2013; Hyeon et al., 2013; Kang and Kim, 2016;
Lee et al., 2019; Ng et al., 2019; Han et al., 2020). Lee et al. (2019)
has recently reported that reduction in osteoclast differentiation
and increased bone density through regulation of ROS signaling
result from reduced RANKL secretion by osteoblasts. However,
we found that Sesn2 regulated osteoclastogenesis through
the NF-κB and MAPK pathways and that Sesn2 did not
affect osteoblast differentiation, ROS generation, or induction
of Ca2+ oscillations. Activations of the antioxidant enzymes
NAD-dependent deacetylase sirtuin 3 (Sirt3) and superoxide
dismutase 2 (SOD2) inhibited osteoclastogenic genes and
NFATc1 expression, formation of mature osteoclasts, and
osteoclast functional activity by reducing mitochondrial ROS
production (Kim et al., 2017). On the other hand, knock-down
of Sesn2 increased lipopolysaccharide-induced ROS production
and apoptosis by inhibiting SOD2 and catalase activity in heart
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FIGURE 3 | Reduced expression of osteoclast differentiation marker genes in Sesn2 KO mice. (A) Expression of mRNAs for the master regulators of
osteoclastogenesis were measured on 2 days after RANKL treatment. Osteoclastogenesis-related gene expression diminished in Sesn2 KO BMMs during osteoclast
differentiation (n = 4). Data were expressed as mean ± S.E.M. *p < 0.05 compared with WT. N.S. = not significant. (B) BMM cells were treated with 100 ng/ml
RANKL for the period indicated. Protein expression of p-JNK (90∼110 kDa), p-ERK (44, 42 kDa), p-p38 (41 kDa), and IκBα (35 kDa) was quantified by
immunoblotting and ImageJ analysis (n = 3). The RANKL-induced activation of the TRAF6 downstream pathways was reduced in Sesn2 KO osteoclasts. Data were
normalized to expression in WT cells and expressed as mean ± S.E.M.
(Hwang et al., 2018). Therefore, Sesn2 may exert its antioxidant
effects via multiple regulatory pathways.
A previous report showed that the TRAF6/p62 interaction and
activation of the NF-kB and/or MAPK pathways play important
roles in RANKL-induced osteoclast differentiation (Duran et al.,
2004). CYLD, a de-ubiquitinating enzyme, physically interacts
with p62, the CYLD/TRAF6 complex negatively regulates TRAF6
ubiquitination and regulates the sustained inhibitory actions of
NF-kB and NFATc1 during RANKL-induced osteoclastogenesis
(Jin et al., 2008). Bae et al. (2013) demonstrated that Sesn2
interacts with Keap1, p62, and ubiquitin ligase and that the
antioxidant activity of Sesn2 is mediated by activation of Nrf2
and p62-dependent autophagic degradation of Keap1 when ROS
is increased as a result of an increase in mTORC1 activity and ER
stress due to environmental stresses. According to these reports, it
has a possibility to regulate the osteoclastogenesis via interactions
between p62/Sesn2 and TRAF6/p62. Although we did not
confirmed the Sesn2 interaction with TRAF6 or p62 under
RANKL-induced osteoclast differentiation, our results combined
with previous reports suggest that Sesn2 promotes a strong
interaction between TRAF6 and p62 and promotes RANKL-
induced osteoclastogenesis via activations of NF-κB and MAPK
Frontiers in Cell and Developmental Biology | www.frontiersin.org 8 March 2021 | Volume 9 | Article 646803
fcell-09-646803 March 22, 2021 Time: 13:41 # 9
Oh et al. Role of Sestrin2 in Osteoclastogenesis
FIGURE 4 | The p62 and TRAF6 interaction is inhibited in Sesn2 KO mice. (A) RANKL-induced ROS generation was measured in WT and Sesn2 KO BMMs (n = 7).
Deletion of Sesn2 had no effect on ROS generation in Sesn2 KO BMMs. The data were normalized to the amount of ROS generated in WT cells and expressed as
mean ± S.E.M. ***p < 0.001 compared with control. N.S. = not significant (Scale bar = 10 µm). (B) The number of RANKL-induced [Ca2+]i oscillations were
measured in WT and Sesn2 KO BMMs (n = 5). Deletion of Sesn2 had no effects on [Ca2+]i oscillations. The data were expressed as means ± S.E.M. ***p < 0.001
compared with control. N.S. = not significant. (C) BMMs from WT and Sesn2 KO mice were treated with RANKL for the period indicated, immunoprecipitated with
anti-TRAF6 antibody, and the precipitates were immunoblotted for p62 (55 kDa) and TRAF6 (60 kDa; n = 3). The Sesn2 deletion inhibited the interaction between
(Continued)
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FIGURE 4 | Continued
p62 and TRAF6. Data were expressed as mean ± SEM. ***p < 0.001 compared with WT. (D) BMMs from Sesn2 KO mice were transfected with Flag-Sesn2 (n = 3).
At 24 h post-transfection, cells were harvested and lysed, and cell lysates were subjected to immunoprecipitation with anti-TRAF6 antibody. The inhibition of
interaction between p62 and TRAF6 in the Sesn2 deletion was recovered by transfection of Sesn2 KO BMMs with Flag-Sesn2. Data were expressed as
mean ± SEM. *p < 0.05 compared with transfected WT. N.S. = not significant. (E) BMMs from WT and Sesn2 KO mice were transfected with pLVX-EIP and
pLVX-EIP-Flag-Sesn2 (n = 3). At 24 h post-infection, cells were treated 50 ng/ml RANKL for 6 days, and then TRAP-stained. TRAP+ MNCs with more than ten
nuclei were scored as osteoclasts. The reduction in TRAP+ osteoclasts in the Sesn2 deletion was recovered to WT levels by transfection of pLVX-EIP-Flag-Sesn2
into Sesn2 KO BMMs when compared to transfection of pLVX-EIP into WT BMMs. Data were expressed as mean ± SEM (Scale bar = 50 µm). **p < 0.01 and
***p < 0.001 compared with RANKL-treated WT BMMs.
FIGURE 5 | A schematic diagram for the regulatory mechanism of osteoclast differentiation by Sestrin2. The model shows the activation of NFATc1 requires
Sestrin2-mediated activation for the TRAF6/p62 interaction (red arrows). The sequence of events activated by RANKL also induces the ROS generation and Ca2+
oscillations that are required for the activation of NFATc1 regardless of Sesstrin2 (blue arrows).
downstream signaling pathways. In addition, to protect cells
against endotoxicity, such as inflammation and aging, Sesn2 is
activated by an increase in oxidative stress-induced Nrf2 and AP-
1 via activation of toll-like receptors, by inhibition of ubiquitin-
mediated Sestrin degradation, and by an increase in Sestrin-
MAPK complexes in immune cells (Wang et al., 2019; Kim et al.,
2020). Further, it has been shown that p62 is highly expressed
in osteoclasts in periapicitis and periodontitis models and that
NOX4 is highly expressed in bones obtained from patients with
osteoporosis and Paget disease, a focal disorder of enhanced bone
remodeling (Goettsch et al., 2013; Li et al., 2014). Recently, it has
been reported that Sestrin expression is suppressed in knee joint
cartilage obtained from osteoarthritis and aging donors (Shen
et al., 2017). Other reports are also showed that Sesn2 expression
reduction in skeletal muscles of old mice is increased expression
and induced autophagy by physical exercise, and Sesn1 and Sesn2
expression are increased by acute aerobic exercise in skeletal
muscle of young mice (Lenhare et al., 2017; Crisol et al., 2018).
Therefore, we suggest that Sesn2 protects against stimulation of
the immune response and aging.
In summary, our results provide strong evidence for the role of
Sesn2 in regulation of RANKL-induced osteoclasts differentiation
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and bone metabolism via the NF-κB and MAPK pathways
and the TRAF6/p62 interactions. Specifically, our findings
suggest that Sesn2 regulates bone remodeling by balancing
autophagy and antioxidant signaling. We believe that our
findings may be clinically relevance for pathological conditions
of the immune and skeletal systems. We demonstrated the
essential roles of Sesn2 in the TRAF6/p62 downstream signaling
pathway during RANKL-induced osteoclast differentiation.
These findings suggest a novel and potent therapeutic target
for various bone and skeletal disorders caused by the abnormal
formation of osteoclasts.
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